Boston Oncology and King Fahd Medical City (KFMC) sign a Letter of Intent to collaborate on the localization of Cell & Gene Therapy in Saudia Arabia this week.
According to KFMC CEO Dr Fahad Al-Ghofaili, the signing ceremony, attended by His Excellency Eng. Abdulaziz AlRamaih, Deputy Minister of Health for Planning and Development, marks a significant step forward in advancing the Kingdom’s medical capabilities and achieving the ambitious goals set forth in Vision 2030.
“Localizing Cell and Gene Therapy in KFMC is an important step to increase local capabilities in advanced treatments and medical technologies, contributing to the goals of the Healthcare Transformation Project,” says Dr Al-Ghofaili.
Boston Oncology CEO Dr Abdullah Baaj says that their centre is renowned for its customer-centered model, bringing extensive expertise in localizing technology.
“We are laser-focused on the real-world needs of patients and hospitals. Boston Oncology is positioned to provide cutting-edge technologies and cell and gene therapies through this partnership. This collaboration will establish a local treatment option, relieving bottlenecks in therapy provision and improving patient outcomes. The resulting Research and Development and clinical trials will significantly contribute to innovative advancements in the healthcare sector of Saudi Arabia,” says Baaj.
Commenting on the partnership Baaj says that KFMC is a go-to destination for clients seeking world-class care.
“KFMC brings world-class clinicians and infrastructure, making it a destination for patients throughout the region. Joining forces to localize Cell and Gene Therapy is a transformative step towards our mission to impact the lives of one billion patients,” says Baaj.
Boston Oncology headquarters is in Cambridge, Massachusetts. The company claims that it is focused on bringing patient-centered solutions and advanced treatment modalities to growing markets.
Baaj says that its new Cell & Gene Therapy entity establishes a fully localized offering to deliver personalized treatments that address the unique genetic profiles of patients.
“By partnering with leading medical institutions and leveraging leading-edge technologies, Boston Oncology CGT is expanding the company’s legacy of transformative advancements in healthcare,” says Baaj.
Notes from the Editor: For more information on Boston Oncology, click here. King Fahad Medical City in Riyadh, Saudi Arabia, stands as one of the largest and most rapidly expanding medical complexes in the Middle East with four hospitals and four specialized medical centers, offering comprehensive healthcare services. For more information click here.
